Aggrecan antibody (N-Term)
Quick Overview for Aggrecan antibody (N-Term) (ABIN1731433)
Target
See all Aggrecan (ACAN) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Specificity
- Reacts with Aggrecan from Human, Gorilla, Monkey, Hamster, Pig
-
Cross-Reactivity
- Rat (Rattus)
-
Cross-Reactivity (Details)
- Predicted to cross react with Mouse, Rat, Bovine, Horse. BLAST analysis of the peptide immunogen showed no homology with other human proteins, except NCAN (56 % ).
-
Purification
- Antiserum
-
Immunogen
- Synthetic 18 amino acid peptide from N-terminus of human ACAN / Aggrecan. Percent identity with other species by BLAST analysis: Human, Gorilla, Monkey, Marmoset, Hamster, Pig (100%), Mouse, Rat, Bovine, Panda, Horse (94%), Dog, Elephant (89%), Bat (83%).
-
Isotype
- IgG
-
-
-
-
Application Notes
-
Working dilution: Optimal dilutions should be determined by the end user.
The following are guidelines only:
IHC - P (7 μg/mL) -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- PBS, Sodium azide 0.1 %
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C/-80 °C
-
Storage Comment
- Long term: -70°C, Short term: +4°C
-
-
- Aggrecan (ACAN)
-
Alternative Name
- ACAN / Aggrecan
-
Background
- Crucial component of the extracellular matrix of cartilagenous tissue. Mutated form of Aggrecan is involved in skeletal dysplasia and spinal degeneration.
-
Gene ID
- 176
-
Pathways
- Glycosaminoglycan Metabolic Process, Dicarboxylic Acid Transport
Target
-